K.C. Fadem
Chief Technology Officer Cognision
Seminars
Thursday 17th September 2026
Cognision360, the First Fully Integrated Digital Biomarker Platform for CNS Trials
10:00 am
- The challenges of implementing advanced neurobiomarkers in CNS trials
- Cognision360 digital biomarker platform, devices, data management, and analyses
- How Cognision360 streamlines the complex implementation of advanced neurobiomarkers
- Benefits to pharma sponsors, trial sites, and contract research organizations
